NF-κB-inducing kinase is dispensable for activation of NF-κB in inflammatory settings but essential for lymphotoxin β receptor activation of NF-κB in primary human fibroblasts

被引:74
作者
Smith, C
Andreakos, E
Crawley, JB
Brennan, FM
Feldmann, M
Foxwell, BMJ
机构
[1] Univ London Imperial Coll Sci & Technol, Sch Med, Kennedy Inst, Rheumatol Div, London W6 8LH, England
[2] Royal Free Hosp, London NW3 2QG, England
关键词
D O I
10.4049/jimmunol.167.10.5895
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The transcription factor NF-kappaB is of major importance in the biology of pro-inflammatory cytokines, such as TNF-alpha and IL-1 alpha, and thereby is intimately involved in the process of inflammation. Understanding the mechanisms by which NF-kappaB is activated in response to inflammatory stimuli has become a major goal of inflammation research. The discovery of NF-KB-inducing kinase (NIK) asa TNFR-associated factor-interacting enzyme and a potential activator of the I kappaB alpha -kinase complex appeared to have identified an important element of the NF-kappaB activition pathway, a view that was supported by several subsequent studies. However, recent experiments in the alymphoplasia (aly/aly) mouse, which has missense point mutation (G885R) in NIK, has challenged that view. The reasons for the discrepancy between the different studies is unclear and could be due to multiple factors, such as cell type, species of cell, or primary vs transformed cell lines. One system that has not been investigated is primary human cells. Using an adenoviral vector encoding kinase-deficient NIK, we have investigated the role of NIK in LPS, IL-1, TNF-alpha, and lymphotoxin (LT) betaR signaling in primary human cells and TNF-a expression from rheumatoid tissue. These data show that, in the primary systems tested, NIK has a restricted role in LT betaR signaling and is not required by the other stimuli tested. Also, there is no apparent role for NIK in the process of TNF-alpha production in human rheumatoid arthritis. These data also highlight the potential problems in extrapolating the function of signaling pathways between primary and transfected cell lines.
引用
收藏
页码:5895 / 5903
页数:9
相关论文
共 68 条
[1]  
Awane M, 1999, J IMMUNOL, V162, P5337
[2]   NF-kappa B: Ten years after [J].
Baeuerle, PA ;
Baltimore, D .
CELL, 1996, 87 (01) :13-20
[3]   Apoptosis: Activate NF-kappa B or die? [J].
Baichwal, VR ;
Baeuerle, PA .
CURRENT BIOLOGY, 1997, 7 (02) :R94-R96
[4]   The transcription factor NF-κB and human disease [J].
Baldwin, AS .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (01) :3-6
[5]   Mechanisms of disease - Nuclear factor-kappa b - A pivotal transcription factor in chronic inflammatory diseases [J].
Barnes, PJ ;
Larin, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (15) :1066-1071
[6]   THE I-KAPPA-B PROTEINS - MULTIFUNCTIONAL REGULATORS OF REL/NF-KAPPA-B TRANSCRIPTION FACTORS [J].
BEG, AA ;
BALDWIN, AS .
GENES & DEVELOPMENT, 1993, 7 (11) :2064-2070
[7]   Role of NF kappa B in the mortality of sepsis [J].
Bohrer, H ;
Qiu, F ;
Zimmerman, T ;
Zhang, YM ;
Jllmer, T ;
Mannel, D ;
Bottiger, BW ;
Stern, DM ;
Waldherr, R ;
Saeger, HD ;
Ziegler, R ;
Bierhaus, A ;
Martin, E ;
Nawroth, PP .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (05) :972-985
[8]  
Bondeson J, 1999, J IMMUNOL, V162, P2939
[9]  
Bondeson J, 2000, J RHEUMATOL, V27, P2078
[10]   Defining therapeutic targets by using adenovirus:: Blocking NF-κB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators [J].
Bondeson, J ;
Foxwell, B ;
Brennan, F ;
Feldmann, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (10) :5668-5673